Invega Sustenna is a long-acting injectable antipsychotic medication used for the treatment of schizophrenia and schizoaffective disorder. It contains the active ingredient paliperidone, which alters the activity of certain natural substances in the brain to help manage symptoms.
Key FeaturesIdeal for patients requiring long-term management of schizophrenia or schizoaffective disorder.
Typical User/Industry ProfileHealthcare professionals treating patients with schizophrenia or schizoaffective disorder.
About the BrandInvega Sustenna is developed by Janssen Pharmaceuticals, a leader in mental health treatments, known for pioneering innovative solutions in the field of antipsychotic medications.